APO Research
Talk to an analyst

APO RESEARCH · REPORT

Nicotinamide Phosphoribosyltransferase

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Nicotinamide Phosphoribosyltransferase Market Analysis and Forecast 2026-2032

19 December 2025198 pages

Choose your research edition.

Industry ResearchNicotinamide Phosphoribosyltransferase Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Nicotinamide Phosphoribosyltransferase Industry Growth and Trends Forecast to 203290 pages · $3,450 USDMarket StructureGlobal Nicotinamide Phosphoribosyltransferase Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032186 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Nicotinamide Phosphoribosyltransferase Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Nicotinamide Phosphoribosyltransferase Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Nicotinamide Phosphoribosyltransferase market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Nicotinamide Phosphoribosyltransferase is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Nicotinamide Phosphoribosyltransferase include OncoTartis, Inc., Karyopharm Therapeutics, Inc., Genentech, Inc., FORMA Therapeutics, Inc., Calico LLC, Aurigene Discovery Technologies Limited and Angelini Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Nicotinamide Phosphoribosyltransferase, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Nicotinamide Phosphoribosyltransferase, also provides the sales of main regions and countries. Of the upcoming market potential for Nicotinamide Phosphoribosyltransferase, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Nicotinamide Phosphoribosyltransferase sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Nicotinamide Phosphoribosyltransferase market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Nicotinamide Phosphoribosyltransferase sales, projected growth trends, production technology, application and end-user industry.

Nicotinamide Phosphoribosyltransferase Segment by Company

OncoTartis, Inc.

Karyopharm Therapeutics, Inc.

Genentech, Inc.

FORMA Therapeutics, Inc.

Calico LLC

Aurigene Discovery Technologies Limited

Angelini Group

Nicotinamide Phosphoribosyltransferase Segment by Type

Lipids

Small Molecule Compounds

Hormone

Others

Nicotinamide Phosphoribosyltransferase Segment by Application

Breast Cancer

Parkinson's Disease

Acute Lung Injury

Others

Nicotinamide Phosphoribosyltransferase Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Nicotinamide Phosphoribosyltransferase market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Nicotinamide Phosphoribosyltransferase and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Nicotinamide Phosphoribosyltransferase.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Nicotinamide Phosphoribosyltransferase in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Nicotinamide Phosphoribosyltransferase manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Nicotinamide Phosphoribosyltransferase sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Nicotinamide Phosphoribosyltransferase Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Lipids Major Manufacturers Table 3. Small Molecule Compounds Major Manufacturers Table 4. Hormone Major Manufacturers Table 5. Others Major Manufacturers Table 6. Global Nicotinamide Phosphoribosyltransferase Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Breast Cancer Major Manufacturers Table 8. Parkinson's Disease Major Manufacturers Table 9. Acute Lung Injury Major Manufacturers Table 10. Others Major Manufacturers Table 11. Nicotinamide Phosphoribosyltransferase Industry Trends Table 12. Nicotinamide Phosphoribosyltransferase Industry Drivers Table 13. Nicotinamide Phosphoribosyltransferase Industry Opportunities and Challenges Table 14. Nicotinamide Phosphoribosyltransferase Industry Restraints Table 15. Global Nicotinamide Phosphoribosyltransferase Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Nicotinamide Phosphoribosyltransferase Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Nicotinamide Phosphoribosyltransferase Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Region (2021-2026) Table 19. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Region (2027-2032) Table 20. Global Nicotinamide Phosphoribosyltransferase Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (W Tons) Table 21. Global Nicotinamide Phosphoribosyltransferase Sales by Region (2021-2026) & (W Tons) Table 22. Global Nicotinamide Phosphoribosyltransferase Sales by Region (2027-2032) & (W Tons) Table 23. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2021-2026) Table 24. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2027-2032) Table 25. Global Nicotinamide Phosphoribosyltransferase Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Nicotinamide Phosphoribosyltransferase Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Manufacturers (2021-2026) Table 29. Global Nicotinamide Phosphoribosyltransferase Sales Price (US$/Ton) of Manufacturers (2021-2026) Table 30. Global Nicotinamide Phosphoribosyltransferase Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Nicotinamide Phosphoribosyltransferase Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Nicotinamide Phosphoribosyltransferase Manufacturers, Product Type & Application Table 33. Global Nicotinamide Phosphoribosyltransferase Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Nicotinamide Phosphoribosyltransferase by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Nicotinamide Phosphoribosyltransferase Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2021-2026) Table 40. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2027-2032) Table 41. Global Nicotinamide Phosphoribosyltransferase Sales by Type 2021 VS 2025 VS 2032 (W Tons) Table 42. Global Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (W Tons) Table 43. Global Nicotinamide Phosphoribosyltransferase Sales by Type (2027-2032) & (W Tons) Table 44. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2021-2026) Table 45. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2027-2032) Table 46. Global Nicotinamide Phosphoribosyltransferase Price by Type (2021-2026) & (US$/Ton) Table 47. Global Nicotinamide Phosphoribosyltransferase Price by Type (2027-2032) & (US$/Ton) Table 48. Global Nicotinamide Phosphoribosyltransferase Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2021-2026) Table 52. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2027-2032) Table 53. Global Nicotinamide Phosphoribosyltransferase Sales by Application 2021 VS 2025 VS 2032 (W Tons) Table 54. Global Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (W Tons) Table 55. Global Nicotinamide Phosphoribosyltransferase Sales by Application (2027-2032) & (W Tons) Table 56. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2021-2026) Table 57. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2027-2032) Table 58. Global Nicotinamide Phosphoribosyltransferase Price by Application (2021-2026) & (US$/Ton) Table 59. Global Nicotinamide Phosphoribosyltransferase Price by Application (2027-2032) & (US$/Ton) Table 60. OncoTartis, Inc. Company Information Table 61. OncoTartis, Inc. Business Overview Table 62. OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 63. OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio Table 64. OncoTartis, Inc. Recent Development Table 65. Karyopharm Therapeutics, Inc. Company Information Table 66. Karyopharm Therapeutics, Inc. Business Overview Table 67. Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio Table 69. Karyopharm Therapeutics, Inc. Recent Development Table 70. Genentech, Inc. Company Information Table 71. Genentech, Inc. Business Overview Table 72. Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio Table 74. Genentech, Inc. Recent Development Table 75. FORMA Therapeutics, Inc. Company Information Table 76. FORMA Therapeutics, Inc. Business Overview Table 77. FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio Table 79. FORMA Therapeutics, Inc. Recent Development Table 80. Calico LLC Company Information Table 81. Calico LLC Business Overview Table 82. Calico LLC Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. Calico LLC Nicotinamide Phosphoribosyltransferase Product Portfolio Table 84. Calico LLC Recent Development Table 85. Aurigene Discovery Technologies Limited Company Information Table 86. Aurigene Discovery Technologies Limited Business Overview Table 87. Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product Portfolio Table 89. Aurigene Discovery Technologies Limited Recent Development Table 90. Angelini Group Company Information Table 91. Angelini Group Business Overview Table 92. Angelini Group Nicotinamide Phosphoribosyltransferase Sales (W Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. Angelini Group Nicotinamide Phosphoribosyltransferase Product Portfolio Table 94. Angelini Group Recent Development Table 95. North America Nicotinamide Phosphoribosyltransferase Revenue by Type (2021-2026) & (US$ Million) Table 96. North America Nicotinamide Phosphoribosyltransferase Revenue by Type (2027-2032) & (US$ Million) Table 97. North America Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (W Tons) Table 98. North America Nicotinamide Phosphoribosyltransferase Sales by Type (2027-2032) & (W Tons) Table 99. North America Nicotinamide Phosphoribosyltransferase Sales Price by Type (2021-2026) & (US$/Ton) Table 100. North America Nicotinamide Phosphoribosyltransferase Sales Price by Type (2027-2032) & (US$/Ton) Table 101. North America Nicotinamide Phosphoribosyltransferase Revenue by Application (2021-2026) & (US$ Million) Table 102. North America Nicotinamide Phosphoribosyltransferase Revenue by Application (2027-2032) & (US$ Million) Table 103. North America Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (W Tons) Table 104. North America Nicotinamide Phosphoribosyltransferase Sales by Application (2027-2032) & (W Tons) Table 105. North America Nicotinamide Phosphoribosyltransferase Sales Price by Application (2021-2026) & (US$/Ton) Table 106. North America Nicotinamide Phosphoribosyltransferase Sales Price by Application (2027-2032) & (US$/Ton) Table 107. North America Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. North America Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. North America Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. North America Nicotinamide Phosphoribosyltransferase Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 111. North America Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026) & (W Tons) Table 112. North America Nicotinamide Phosphoribosyltransferase Sales by Country (2027-2032) & (W Tons) Table 113. North America Nicotinamide Phosphoribosyltransferase Sales Price by Country (2021-2026) & (US$/Ton) Table 114. North America Nicotinamide Phosphoribosyltransferase Sales Price by Country (2027-2032) & (US$/Ton) Table 115. United States Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 116. Canada Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 117. Europe Nicotinamide Phosphoribosyltransferase Revenue by Type (2021-2026) & (US$ Million) Table 118. Europe Nicotinamide Phosphoribosyltransferase Revenue by Type (2027-2032) & (US$ Million) Table 119. Europe Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (W Tons) Table 120. Europe Nicotinamide Phosphoribosyltransferase Sales by Type (2027-2032) & (W Tons) Table 121. Europe Nicotinamide Phosphoribosyltransferase Sales Price by Type (2021-2026) & (US$/Ton) Table 122. Europe Nicotinamide Phosphoribosyltransferase Sales Price by Type (2027-2032) & (US$/Ton) Table 123. Europe Nicotinamide Phosphoribosyltransferase Revenue by Application (2021-2026) & (US$ Million) Table 124. Europe Nicotinamide Phosphoribosyltransferase Revenue by Application (2027-2032) & (US$ Million) Table 125. Europe Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (W Tons) Table 126. Europe Nicotinamide Phosphoribosyltransferase Sales by Application (2027-2032) & (W Tons) Table 127. Europe Nicotinamide Phosphoribosyltransferase Sales Price by Application (2021-2026) & (US$/Ton) Table 128. Europe Nicotinamide Phosphoribosyltransferase Sales Price by Application (2027-2032) & (US$/Ton) Table 129. Europe Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Europe Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 131. Europe Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 132. Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 133. Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026) & (W Tons) Table 134. Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2027-2032) & (W Tons) Table 135. Europe Nicotinamide Phosphoribosyltransferase Sales Price by Country (2021-2026) & (US$/Ton) Table 136. Europe Nicotinamide Phosphoribosyltransferase Sales Price by Country (2027-2032) & (US$/Ton) Table 137. Germany Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 138. France Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 139. U.K. Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 140. Italy Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 141. Netherlands Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 142. China Nicotinamide Phosphoribosyltransferase Revenue by Type (2021-2026) & (US$ Million) Table 143. China Nicotinamide Phosphoribosyltransferase Revenue by Type (2027-2032) & (US$ Million) Table 144. China Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (W Tons) Table 145. China Nicotinamide Phosphoribosyltransferase Sales by Type (2027-2032) & (W Tons) Table 146. China Nicotinamide Phosphoribosyltransferase Sales Price by Type (2021-2026) & (US$/Ton) Table 147. China Nicotinamide Phosphoribosyltransferase Sales Price by Type (2027-2032) & (US$/Ton) Table 148. China Nicotinamide Phosphoribosyltransferase Revenue by Application (2021-2026) & (US$ Million) Table 149. China Nicotinamide Phosphoribosyltransferase Revenue by Application (2027-2032) & (US$ Million) Table 150. China Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (W Tons) Table 151. China Nicotinamide Phosphoribosyltransferase Sales by Application (2027-2032) & (W Tons) Table 152. China Nicotinamide Phosphoribosyltransferase Sales Price by Application (2021-2026) & (US$/Ton) Table 153. China Nicotinamide Phosphoribosyltransferase Sales Price by Application (2027-2032) & (US$/Ton) Table 154. Asia Nicotinamide Phosphoribosyltransferase Revenue by Type (2021-2026) & (US$ Million) Table 155. Asia Nicotinamide Phosphoribosyltransferase Revenue by Type (2027-2032) & (US$ Million) Table 156. Asia Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (W Tons) Table 157. Asia Nicotinamide Phosphoribosyltransferase Sales by Type (2027-2032) & (W Tons) Table 158. Asia Nicotinamide Phosphoribosyltransferase Sales Price by Type (2021-2026) & (US$/Ton) Table 159. Asia Nicotinamide Phosphoribosyltransferase Sales Price by Type (2027-2032) & (US$/Ton) Table 160. Asia Nicotinamide Phosphoribosyltransferase Revenue by Application (2021-2026) & (US$ Million) Table 161. Asia Nicotinamide Phosphoribosyltransferase Revenue by Application (2027-2032) & (US$ Million) Table 162. Asia Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (W Tons) Table 163. Asia Nicotinamide Phosphoribosyltransferase Sales by Application (2027-2032) & (W Tons) Table 164. Asia Nicotinamide Phosphoribosyltransferase Sales Price by Application (2021-2026) & (US$/Ton) Table 165. Asia Nicotinamide Phosphoribosyltransferase Sales Price by Application (2027-2032) & (US$/Ton) Table 166. Asia Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. Asia Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 168. Asia Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 169. Asia Nicotinamide Phosphoribosyltransferase Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 170. Asia Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026) & (W Tons) Table 171. Asia Nicotinamide Phosphoribosyltransferase Sales by Country (2027-2032) & (W Tons) Table 172. Asia Nicotinamide Phosphoribosyltransferase Sales Price by Country (2021-2026) & (US$/Ton) Table 173. Asia Nicotinamide Phosphoribosyltransferase Sales Price by Country (2027-2032) & (US$/Ton) Table 174. Japan Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 175. South Korea Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 176. India Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 177. Australia Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 178. China Taiwan Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 179. Southeast Asia Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 180. SAMEA Nicotinamide Phosphoribosyltransferase Revenue by Type (2021-2026) & (US$ Million) Table 181. SAMEA Nicotinamide Phosphoribosyltransferase Revenue by Type (2027-2032) & (US$ Million) Table 182. SAMEA Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2026) & (W Tons) Table 183. SAMEA Nicotinamide Phosphoribosyltransferase Sales by Type (2027-2032) & (W Tons) Table 184. SAMEA Nicotinamide Phosphoribosyltransferase Sales Price by Type (2021-2026) & (US$/Ton) Table 185. SAMEA Nicotinamide Phosphoribosyltransferase Sales Price by Type (2027-2032) & (US$/Ton) Table 186. SAMEA Nicotinamide Phosphoribosyltransferase Revenue by Application (2021-2026) & (US$ Million) Table 187. SAMEA Nicotinamide Phosphoribosyltransferase Revenue by Application (2027-2032) & (US$ Million) Table 188. SAMEA Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2026) & (W Tons) Table 189. SAMEA Nicotinamide Phosphoribosyltransferase Sales by Application (2027-2032) & (W Tons) Table 190. SAMEA Nicotinamide Phosphoribosyltransferase Sales Price by Application (2021-2026) & (US$/Ton) Table 191. SAMEA Nicotinamide Phosphoribosyltransferase Sales Price by Application (2027-2032) & (US$/Ton) Table 192. SAMEA Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 193. SAMEA Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 194. SAMEA Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 195. SAMEA Nicotinamide Phosphoribosyltransferase Sales by Country (2021 VS 2025 VS 2032) & (W Tons) Table 196. SAMEA Nicotinamide Phosphoribosyltransferase Sales by Country (2021-2026) & (W Tons) Table 197. SAMEA Nicotinamide Phosphoribosyltransferase Sales by Country (2027-2032) & (W Tons) Table 198. SAMEA Nicotinamide Phosphoribosyltransferase Sales Price by Country (2021-2026) & (US$/Ton) Table 199. SAMEA Nicotinamide Phosphoribosyltransferase Sales Price by Country (2027-2032) & (US$/Ton) Table 200. Brazil Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 201. Argentina Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 202. Chile Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 203. Colombia Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 204. Peru Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 205. Saudi Arabia Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 206. Israel Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 207. UAE Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 208. Turkey Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 209. Iran Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 210. Egypt Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Table 211. Key Raw Materials Table 212. Raw Materials Key Suppliers Table 213. Nicotinamide Phosphoribosyltransferase Distributors List Table 214. Nicotinamide Phosphoribosyltransferase Customers List Table 215. Research Programs/Design for This Report Table 216. Authors List of This Report Table 217. Secondary Sources Table 218. Primary Sources List of Figures Figure 1. Nicotinamide Phosphoribosyltransferase Image Figure 2. Global Nicotinamide Phosphoribosyltransferase Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Nicotinamide Phosphoribosyltransferase Market Size Share 2021 VS 2025 VS 2032 Figure 4. Lipids Image Figure 5. Small Molecule Compounds Image Figure 6. Hormone Image Figure 7. Others Image Figure 8. Global Nicotinamide Phosphoribosyltransferase Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Nicotinamide Phosphoribosyltransferase Market Size Share 2021 VS 2025 VS 2032 Figure 10. Breast Cancer Image Figure 11. Parkinson's Disease Image Figure 12. Acute Lung Injury Image Figure 13. Others Image Figure 14. Global Nicotinamide Phosphoribosyltransferase Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Nicotinamide Phosphoribosyltransferase Revenue (2021-2032) & (US$ Million) Figure 16. Global Nicotinamide Phosphoribosyltransferase Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Region (2021-2032) Figure 19. Global Nicotinamide Phosphoribosyltransferase Sales (2021-2032) & (W Tons) Figure 20. Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2021 VS 2025 VS 2032 (W Tons) Figure 21. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Nicotinamide Phosphoribosyltransferase Sales YoY (2021-2032) & (W Tons) Figure 23. Europe Nicotinamide Phosphoribosyltransferase Sales YoY (2021-2032) & (W Tons) Figure 24. China Nicotinamide Phosphoribosyltransferase Sales YoY (2021-2032) & (W Tons) Figure 25. Asia (Excluding China) Nicotinamide Phosphoribosyltransferase Sales YoY (2021-2032) & (W Tons) Figure 26. South America, Middle East and Africa Nicotinamide Phosphoribosyltransferase Sales YoY (2021-2032) & (W Tons) Figure 27. Global Nicotinamide Phosphoribosyltransferase Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Nicotinamide Phosphoribosyltransferase Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2021-2032) Figure 33. Global Nicotinamide Phosphoribosyltransferase Sales by Type (2021 VS 2025 VS 2032) & (W Tons) Figure 34. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2021-2032) Figure 36. Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2021-2032) Figure 39. Global Nicotinamide Phosphoribosyltransferase Sales by Application (2021 VS 2025 VS 2032) & (W Tons) Figure 40. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2021-2032) Figure 42. North America Nicotinamide Phosphoribosyltransferase Revenue Share by Type (2021-2032) Figure 43. North America Nicotinamide Phosphoribosyltransferase Sales Share by Type (2021-2032) Figure 44. North America Nicotinamide Phosphoribosyltransferase Revenue Share by Application (2021-2032) Figure 45. North America Nicotinamide Phosphoribosyltransferase Sales Share by Application (2021-2032) Figure 46. North America Nicotinamide Phosphoribosyltransferase Revenue Share by Country (2021-2032) Figure 47. North America Nicotinamide Phosphoribosyltransferase Sales Share by Country (2021-2032) Figure 48. Europe Nicotinamide Phosphoribosyltransferase Revenue Share by Type (2021-2032) Figure 49. Europe Nicotinamide Phosphoribosyltransferase Sales Share by Type (2021-2032) Figure 50. Europe Nicotinamide Phosphoribosyltransferase Revenue Share by Application (2021-2032) Figure 51. Europe Nicotinamide Phosphoribosyltransferase Sales Share by Application (2021-2032) Figure 52. Europe Nicotinamide Phosphoribosyltransferase Revenue Share by Country (2021-2032) Figure 53. Europe Nicotinamide Phosphoribosyltransferase Sales Share by Country (2021-2032) Figure 54. China Nicotinamide Phosphoribosyltransferase Revenue Share by Type (2021-2032) Figure 55. China Nicotinamide Phosphoribosyltransferase Sales Share by Type (2021-2032) Figure 56. China Nicotinamide Phosphoribosyltransferase Revenue Share by Application (2021-2032) Figure 57. China Nicotinamide Phosphoribosyltransferase Sales Share by Application (2021-2032) Figure 58. Asia Nicotinamide Phosphoribosyltransferase Revenue Share by Type (2021-2032) Figure 59. Asia Nicotinamide Phosphoribosyltransferase Sales Share by Type (2021-2032) Figure 60. Asia Nicotinamide Phosphoribosyltransferase Revenue Share by Application (2021-2032) Figure 61. Asia Nicotinamide Phosphoribosyltransferase Sales Share by Application (2021-2032) Figure 62. Asia Nicotinamide Phosphoribosyltransferase Revenue Share by Country (2021-2032) Figure 63. Asia Nicotinamide Phosphoribosyltransferase Sales Share by Country (2021-2032) Figure 64. SAMEA Nicotinamide Phosphoribosyltransferase Revenue Share by Type (2021-2032) Figure 65. SAMEA Nicotinamide Phosphoribosyltransferase Sales Share by Type (2021-2032) Figure 66. SAMEA Nicotinamide Phosphoribosyltransferase Revenue Share by Application (2021-2032) Figure 67. SAMEA Nicotinamide Phosphoribosyltransferase Sales Share by Application (2021-2032) Figure 68. SAMEA Nicotinamide Phosphoribosyltransferase Revenue Share by Country (2021-2032) Figure 69. SAMEA Nicotinamide Phosphoribosyltransferase Sales Share by Country (2021-2032) Figure 70. Nicotinamide Phosphoribosyltransferase Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Nicotinamide Phosphoribosyltransferase Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Lipids
  • Small Molecule Compounds
  • Hormone
  • Others
Applications
  • Breast Cancer
  • Parkinson's Disease
  • Acute Lung Injury
  • Others
Companies covered
  • OncoTartis, Inc.
  • Karyopharm Therapeutics, Inc.
  • Genentech, Inc.
  • FORMA Therapeutics, Inc.
  • Calico LLC
  • Aurigene Discovery Technologies Limited
  • Angelini Group

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Nicotinamide Phosphoribosyltransferase Market by Type
  3. 1.2.1 Global Nicotinamide Phosphoribosyltransferase Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Lipids
  5. 1.2.3 Small Molecule Compounds
  6. 1.2.4 Hormone
  7. 1.2.5 Others
  8. 1.3 Nicotinamide Phosphoribosyltransferase Market by Application
  9. 1.3.1 Global Nicotinamide Phosphoribosyltransferase Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Breast Cancer
  11. 1.3.3 Parkinson's Disease
  12. 1.3.4 Acute Lung Injury
  13. 1.3.5 Others
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Nicotinamide Phosphoribosyltransferase Market Dynamics
  1. 2.1 Nicotinamide Phosphoribosyltransferase Industry Trends
  2. 2.2 Nicotinamide Phosphoribosyltransferase Industry Drivers
  3. 2.3 Nicotinamide Phosphoribosyltransferase Industry Opportunities and Challenges
  4. 2.4 Nicotinamide Phosphoribosyltransferase Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Nicotinamide Phosphoribosyltransferase Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Region
  3. 3.2.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Region (2021-2026)
  5. 3.2.3 Global Nicotinamide Phosphoribosyltransferase Revenue by Region (2027-2032)
  6. 3.2.4 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Nicotinamide Phosphoribosyltransferase Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Nicotinamide Phosphoribosyltransferase Sales by Region
  9. 3.4.1 Global Nicotinamide Phosphoribosyltransferase Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Nicotinamide Phosphoribosyltransferase Sales by Region (2021-2026)
  11. 3.4.3 Global Nicotinamide Phosphoribosyltransferase Sales by Region (2027-2032)
  12. 3.4.4 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Manufacturers
  2. 4.1.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Nicotinamide Phosphoribosyltransferase Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Nicotinamide Phosphoribosyltransferase Sales by Manufacturers
  6. 4.2.1 Global Nicotinamide Phosphoribosyltransferase Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Nicotinamide Phosphoribosyltransferase Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Nicotinamide Phosphoribosyltransferase Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Nicotinamide Phosphoribosyltransferase Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Nicotinamide Phosphoribosyltransferase Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Nicotinamide Phosphoribosyltransferase Manufacturers, Product Type & Application
  13. 4.7 Global Nicotinamide Phosphoribosyltransferase Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Nicotinamide Phosphoribosyltransferase Market CR5 and HHI
  16. 4.8.2 2025 Nicotinamide Phosphoribosyltransferase Tier 1, Tier 2, and Tier 3
5 Nicotinamide Phosphoribosyltransferase Market by Type
  1. 5.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Type
  2. 5.1.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Nicotinamide Phosphoribosyltransferase Sales by Type
  6. 5.2.1 Global Nicotinamide Phosphoribosyltransferase Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2032) & (W Tons)
  8. 5.2.3 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Type (2021-2032)
  9. 5.3 Global Nicotinamide Phosphoribosyltransferase Price by Type
6 Nicotinamide Phosphoribosyltransferase Market by Application
  1. 6.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Application
  2. 6.1.1 Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Nicotinamide Phosphoribosyltransferase Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Nicotinamide Phosphoribosyltransferase Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Nicotinamide Phosphoribosyltransferase Sales by Application
  6. 6.2.1 Global Nicotinamide Phosphoribosyltransferase Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2032) & (W Tons)
  8. 6.2.3 Global Nicotinamide Phosphoribosyltransferase Sales Market Share by Application (2021-2032)
  9. 6.3 Global Nicotinamide Phosphoribosyltransferase Price by Application
7 Company Profiles
  1. 7.1 OncoTartis, Inc.
  2. 7.1.1 OncoTartis, Inc. Company Information
  3. 7.1.2 OncoTartis, Inc. Business Overview
  4. 7.1.3 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 OncoTartis, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
  6. 7.1.5 OncoTartis, Inc. Recent Developments
  7. 7.2 Karyopharm Therapeutics, Inc.
  8. 7.2.1 Karyopharm Therapeutics, Inc. Company Information
  9. 7.2.2 Karyopharm Therapeutics, Inc. Business Overview
  10. 7.2.3 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Karyopharm Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
  12. 7.2.5 Karyopharm Therapeutics, Inc. Recent Developments
  13. 7.3 Genentech, Inc.
  14. 7.3.1 Genentech, Inc. Company Information
  15. 7.3.2 Genentech, Inc. Business Overview
  16. 7.3.3 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Genentech, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
  18. 7.3.5 Genentech, Inc. Recent Developments
  19. 7.4 FORMA Therapeutics, Inc.
  20. 7.4.1 FORMA Therapeutics, Inc. Company Information
  21. 7.4.2 FORMA Therapeutics, Inc. Business Overview
  22. 7.4.3 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 FORMA Therapeutics, Inc. Nicotinamide Phosphoribosyltransferase Product Portfolio
  24. 7.4.5 FORMA Therapeutics, Inc. Recent Developments
  25. 7.5 Calico LLC
  26. 7.5.1 Calico LLC Company Information
  27. 7.5.2 Calico LLC Business Overview
  28. 7.5.3 Calico LLC Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Calico LLC Nicotinamide Phosphoribosyltransferase Product Portfolio
  30. 7.5.5 Calico LLC Recent Developments
  31. 7.6 Aurigene Discovery Technologies Limited
  32. 7.6.1 Aurigene Discovery Technologies Limited Company Information
  33. 7.6.2 Aurigene Discovery Technologies Limited Business Overview
  34. 7.6.3 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Aurigene Discovery Technologies Limited Nicotinamide Phosphoribosyltransferase Product Portfolio
  36. 7.6.5 Aurigene Discovery Technologies Limited Recent Developments
  37. 7.7 Angelini Group
  38. 7.7.1 Angelini Group Company Information
  39. 7.7.2 Angelini Group Business Overview
  40. 7.7.3 Angelini Group Nicotinamide Phosphoribosyltransferase Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Angelini Group Nicotinamide Phosphoribosyltransferase Product Portfolio
  42. 7.7.5 Angelini Group Recent Developments
8 North America
  1. 8.1 North America Nicotinamide Phosphoribosyltransferase Market Size by Type
  2. 8.1.1 North America Nicotinamide Phosphoribosyltransferase Revenue by Type (2021-2032)
  3. 8.1.2 North America Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2032)
  4. 8.1.3 North America Nicotinamide Phosphoribosyltransferase Price by Type (2021-2032)
  5. 8.2 North America Nicotinamide Phosphoribosyltransferase Market Size by Application
  6. 8.2.1 North America Nicotinamide Phosphoribosyltransferase Revenue by Application (2021-2032)
  7. 8.2.2 North America Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2032)
  8. 8.2.3 North America Nicotinamide Phosphoribosyltransferase Price by Application (2021-2032)
  9. 8.3 North America Nicotinamide Phosphoribosyltransferase Market Size by Country
  10. 8.3.1 North America Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Nicotinamide Phosphoribosyltransferase Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Nicotinamide Phosphoribosyltransferase Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Nicotinamide Phosphoribosyltransferase Market Size by Type
  2. 9.1.1 Europe Nicotinamide Phosphoribosyltransferase Revenue by Type (2021-2032)
  3. 9.1.2 Europe Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2032)
  4. 9.1.3 Europe Nicotinamide Phosphoribosyltransferase Price by Type (2021-2032)
  5. 9.2 Europe Nicotinamide Phosphoribosyltransferase Market Size by Application
  6. 9.2.1 Europe Nicotinamide Phosphoribosyltransferase Revenue by Application (2021-2032)
  7. 9.2.2 Europe Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2032)
  8. 9.2.3 Europe Nicotinamide Phosphoribosyltransferase Price by Application (2021-2032)
  9. 9.3 Europe Nicotinamide Phosphoribosyltransferase Market Size by Country
  10. 9.3.1 Europe Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Nicotinamide Phosphoribosyltransferase Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Nicotinamide Phosphoribosyltransferase Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Nicotinamide Phosphoribosyltransferase Market Size by Type
  2. 10.1.1 China Nicotinamide Phosphoribosyltransferase Revenue by Type (2021-2032)
  3. 10.1.2 China Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2032)
  4. 10.1.3 China Nicotinamide Phosphoribosyltransferase Price by Type (2021-2032)
  5. 10.2 China Nicotinamide Phosphoribosyltransferase Market Size by Application
  6. 10.2.1 China Nicotinamide Phosphoribosyltransferase Revenue by Application (2021-2032)
  7. 10.2.2 China Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2032)
  8. 10.2.3 China Nicotinamide Phosphoribosyltransferase Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Nicotinamide Phosphoribosyltransferase Market Size by Type
  2. 11.1.1 Asia Nicotinamide Phosphoribosyltransferase Revenue by Type (2021-2032)
  3. 11.1.2 Asia Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2032)
  4. 11.1.3 Asia Nicotinamide Phosphoribosyltransferase Price by Type (2021-2032)
  5. 11.2 Asia Nicotinamide Phosphoribosyltransferase Market Size by Application
  6. 11.2.1 Asia Nicotinamide Phosphoribosyltransferase Revenue by Application (2021-2032)
  7. 11.2.2 Asia Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2032)
  8. 11.2.3 Asia Nicotinamide Phosphoribosyltransferase Price by Application (2021-2032)
  9. 11.3 Asia Nicotinamide Phosphoribosyltransferase Market Size by Country
  10. 11.3.1 Asia Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Nicotinamide Phosphoribosyltransferase Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Nicotinamide Phosphoribosyltransferase Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Nicotinamide Phosphoribosyltransferase Market Size by Type
  2. 12.1.1 SAMEA Nicotinamide Phosphoribosyltransferase Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Nicotinamide Phosphoribosyltransferase Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Nicotinamide Phosphoribosyltransferase Price by Type (2021-2032)
  5. 12.2 SAMEA Nicotinamide Phosphoribosyltransferase Market Size by Application
  6. 12.2.1 SAMEA Nicotinamide Phosphoribosyltransferase Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Nicotinamide Phosphoribosyltransferase Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Nicotinamide Phosphoribosyltransferase Price by Application (2021-2032)
  9. 12.3 SAMEA Nicotinamide Phosphoribosyltransferase Market Size by Country
  10. 12.3.1 SAMEA Nicotinamide Phosphoribosyltransferase Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Nicotinamide Phosphoribosyltransferase Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Nicotinamide Phosphoribosyltransferase Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Nicotinamide Phosphoribosyltransferase Value Chain Analysis
  2. 13.1.1 Nicotinamide Phosphoribosyltransferase Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Nicotinamide Phosphoribosyltransferase Production Mode & Process
  6. 13.2 Nicotinamide Phosphoribosyltransferase Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Nicotinamide Phosphoribosyltransferase Distributors
  9. 13.2.3 Nicotinamide Phosphoribosyltransferase Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst